1 Epidemiological Measures I Screening for Disease.

Slides:



Advertisements
Similar presentations
Validity and Reliability of Analytical Tests. Analytical Tests include both: Screening Tests Diagnostic Tests.
Advertisements

Likelihood ratios Why these are the most thrilling statistics in Emergency Medicine.
SCREENING CHP400: Community Health Program-lI Mohamed M. B. Alnoor
TESTING A TEST Ian McDowell Department of Epidemiology & Community Medicine November, 2004.
© Tan,Steinbach, Kumar Introduction to Data Mining 4/18/ Other Classification Techniques 1.Nearest Neighbor Classifiers 2.Support Vector Machines.
Laboratory Training for Field Epidemiologists Sensitivity and specificity Predictive values positive and negative Interpretation of results Sep 2007.
Sensitivity, Specificity and ROC Curve Analysis.
SCREENING FOR DISEASE Nigel Paneth. THREE KEY MEASURES OF VALIDITY 1.SENSITIVITY 2.SPECIFICITY 3.PREDICTIVE VALUE.
The University of Texas at Austin, CS 395T, Spring 2008, Prof. William H. Press 1 Computational Statistics with Application to Bioinformatics Prof. William.
GerstmanChapter 41 Epidemiology Kept Simple Chapter 4 Screening for Disease.
Lecture 5 – Clinical Testing Understanding the process of diagnosis and clinical testing Mathew J. Reeves BVSc, PhD Associate Professor, Epidemiology EPI-546.
Epidemiology Kept Simple Chapter 4 Screening for Disease.
Darlene Goldstein 29 January 2003 Receiver Operating Characteristic Methodology.
Statistical Fridays J C Horrow, MD, MSSTAT
Decision Theory Naïve Bayes ROC Curves
Jeremy Wyatt Thanks to Gavin Brown
Baye’s Rule and Medical Screening Tests. Baye’s Rule Baye’s Rule is used in medicine and epidemiology to calculate the probability that an individual.
IE486 Work Analysis & Design II Lab 4 – Upper Limb Assessment Supplementary Notes on Evaluation of Analysis Tools March 23, 2007 Vincent G. Duffy, IE &
Lucila Ohno-Machado An introduction to calibration and discrimination methods HST951 Medical Decision Support Harvard Medical School Massachusetts Institute.
Screening revision! By Ilona Blee. What are some UK Screening programmes?  Antenatal & newborn screening  Newborn Blood Spot  Newborn Hearing Screening.
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
Screening for Disease Guan Peng Department of Epidemiology School of Public Health, CMU.
(Medical) Diagnostic Testing. The situation Patient presents with symptoms, and is suspected of having some disease. Patient either has the disease or.
What is Screening? Basic Public Health Concepts Sheila West, Ph.D. El Maghraby Professor of Ophthalmology Wilmer Eye Institute Johns Hopkins University.
Interpreting Diagnostic Tests
Screening Test for Occult Cancer 100 patients with occult cancer: 95 have "x" in their blood 100 patients without occult cancer: 95 do not have "x" in.
BASIC STATISTICS: AN OXYMORON? (With a little EPI thrown in…) URVASHI VAID MD, MS AUG 2012.
Medical decision making. 2 Predictive values 57-years old, Weight loss, Numbness, Mild fewer What is the probability of low back cancer? Base on demographic.
Stats Tutorial. Is My Coin Fair? Assume it is no different from others (null hypothesis) When will you no longer accept this assumption?
Lecture 4: Assessing Diagnostic and Screening Tests
Basic statistics 11/09/13.
Diagnostic Testing Ethan Cowan, MD, MS Department of Emergency Medicine Jacobi Medical Center Department of Epidemiology and Population Health Albert Einstein.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Indices of Performances of CPRs Nicola.
SCREENING Asst. Prof. Sumattna Glangkarn RN, MSc. (Epidemiology), PhD (Nursing studies)
Sensitivity Sensitivity answers the following question: If a person has a disease, how often will the test be positive (true positive rate)? i.e.: if the.
Statistics. Statistics = everything you need to know, but continually want to forget!!!!
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Sensitivity & Specificity Sam Thomson 8/12/10. Sensitivity Proportion of people with the condition who have a positive test result Proportion of people.
MEASURES OF TEST ACCURACY AND ASSOCIATIONS DR ODIFE, U.B SR, EDM DIVISION.
Appraising A Diagnostic Test
Likelihood 2005/5/22. Likelihood  probability I am likelihood I am probability.
Evidence-Based Medicine Diagnosis Component 2 / Unit 5 1 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
Chapter 10 Screening for Disease
SCREENING Dr. Aliya Hisam Community Medicine Dept. Army Medical College, RWP.
Evaluating Results of Learning Blaž Zupan
TESTING A TEST Ian McDowell Department of Epidemiology & Community Medicine January 2008.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
HSS4303B – Intro to Epidemiology Feb 8, Agreement.
Diagnostic Tests Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /7/20151.
1 Wrap up SCREENING TESTS. 2 Screening test The basic tool of a screening program easy to use, rapid and inexpensive. 1.2.
Diagnostic Tests Studies 87/3/2 “How to read a paper” workshop Kamran Yazdani, MD MPH.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
1 Medical Epidemiology Interpreting Medical Tests and Other Evidence.
Diagnostic Test Characteristics Professor Mobeen Iqbal Shifa College of Medicine.
10 May Understanding diagnostic tests Evan Sergeant AusVet Animal Health Services.
Evaluating Classification Performance
Laboratory Medicine: Basic QC Concepts M. Desmond Burke, MD.
Timothy Wiemken, PhD MPH Assistant Professor Division of Infectious Diseases Diagnostic Tests.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
Biostatistics Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016.
Critical Appraisal Course for Emergency Medicine Trainees Module 5 Evaluation of a Diagnostic Test.
دکتر حمیدرضا صابری
Performance of a diagnostic test Tunisia, 31 Oct 2014
Sensitivity and Specificity
Class session 7 Screening, validity, reliability
بسم الله الرحمن الرحيم Clinical Epidemiology
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Diagnosis II Dr. Brent E. Faught, Ph.D. Assistant Professor
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
House Sales What proportion of the houses that sold for over $600,000 were on the market for less than 30 days? Days on the market Less than 30 days 30.
Presentation transcript:

1 Epidemiological Measures I Screening for Disease

2 Terminology ReliabilityagreementReliability ≡ agreement of ratings/diagnoses, “reproducibility” –Inter-rater reliability –Inter-rater reliability ≡ agreement between two independent raters –Intra-rater reliability –Intra-rater reliability ≡ agreement of the same rater with him/herself ValidityValidity ≡ ability to discriminate without error AccuracyAccuracy ≡ a combination of reliability and validity

3 Validity Compare screening test results to a gold standard (“definitive diagnosis”) Each patient is classified as either true positive (TP), true negative (TN), false positive (FP), or false negative (FN) Test D+D−D−Total T+TPFPTP+FP T−FNTNFN+TN TotalTP+FNFP+TNN

4 Sensitivity Test D+D−D−Total T+TPFPTP+FP T−FNTNFN+TN TotalTP+FNFP+TNN SEN ≡ proportion of cases that test positive or the proportion of those with the disease of interest that our test is able to detect.

Sensitivity Sensitivity = TP/TP+FN Sensitivity =Test positive/Those with disease SnOUT; A very sensitivity test is useful because it allows us to rule out diseases. If you test negative on a very sensitive test then you are probably disease free.

6 Specificity SPEC ≡ proportion of noncases that test negative Test D+D−D−Total T+TPFPTP+FP T−FNTNFN+TN TotalTP+FNFP+TNN

Specificity sPIN ;a very specific test enables us to rule in those with a disease. A positive outcome on a specific test is most likely indicative of disease.

Attributes Both sensitivity and specificity are intrinsic attributes of a test. They do not change with the disease prevalence.

PREDICTIVE VALUES

10 Predictive Value Positive Test D+D−D−Total T+TPFPTP+FP T−FNTNFN+TN TotalTP+FNFP+TNN PVP ≡ proportion of positive tests that are true cases

11 Predictive Value Negative Test D+D−D−Total T+TPFPTP+FP T−FNTNFN+TN TotalTP+FNFP+TNN PVN ≡ proportion of negative tests that are true non-cases

12 Prevalence [True] prevalence = (TP + FN) / N Apparent prevalence = (TP + FP) / N Test D+D−D−Total T+TPFPTP+FP T−FNTNFN+TN TotalTP+FNFP+TNN

Predictive value attributes Both the positive and negative predictive values are affected by prevalence.

14 Conditional Probability Notation Pr(A|B) ≡ “the probability of A given B” For example Pr(T+|D+) ≡ “probability test positive given disease positive” = SENsitivity SPEC ≡ Pr(T−|D−) PVP = Pr(D+|T+) PVN= Pr(D−|T−)

15 Example Low Prevalence Population D+D−Total T+ T− Total ,000,000 Conditions: N = 1,000,000; Prevalence =.001 Prevalence = (those with disease) / N Therefore: (Those with disease) = Prevalence × N =.001× 1,000,000 = 1000

16 Example: Low Prevalence Population D+D−Total T+ T− Total ,000 1,000,000 Number of non-cases, i.e., TN + FP 1,000,000 – 1,000 = 999,000

17 Example: Low Prevalence Population D+D−Total T+990 T− Total1000 TP = SEN × (those with disease) = 0.99 × 1000 = 990 Assume test SENsitivity = 99% i.e., Test will pick up 99% of those with disease

18 Example: Low Prevalence Population D+D−Total T+990 T− 10 Total1000 FN = 1000 – 990 = 10 It follows that:

19 Example: Low Prevalence Population D+D−Total T+ T− 989,010 Total999,000 TN = SPEC × (those without disease) = 0.99 × 999,000 = 989,010 Suppose test SPECificity =.99 i.e., it will correctly identify 99% of the noncases

20 Example: Low Prevalence Population D+D−Total T+ 9,990 T−989,010 Total999,000 FPs = 999,000 – 989,010 = 9,900 It follows that:

21 Example: Low Prevalence Population D+D−Total T+9909,99010,980 T−10989,010989,020 Total ,0001,000,000 PVPT = TP / (TP + FP) = 990 / 10,980 = Low PVP It follows that the Predictive Value Positive is :

22 Example: Low Prevalence Population D+D−Total T+9909,99010,980 T−10989,010989,020 Total ,0001,000,000 PVNT= TN / (all those who test negative) = / =.9999 It follows that the Predictive Value Negative is:

23 Example: High prevalence population D+D−Total T+99,0009,000108,000 T−1,000891,000892,000 Total100,000900,0001,000,000 SEN = / 100,000 = 0.99 SPEC = 891,000 / 900,000 = 0.99 Prev = / 1,000,000 = 0.10 Same test parameters but used in population with true prevalence of.10

24 Example: High prevalence population D+D−Total T+99,0009,000108,000 T−1,000891,000892,000 Total100,000900,0001,000,000 PVP = 99,000 / 108,000 = 0.92 PVN = 891,000 / 892,000 = Prevalence = / 1,000,000 = 0.10 An HIV screening test is used in one million people. Prevalence in population is now 10%. SEN and SPEC are again 99%.

25 PVPT and Prevalence As PREValence increases PVPT also increases

26 Screening Strategy First stage  high SENS (don’t want to miss cases) Second stage  high SPEC (sort out false positives from true positives)

27 Selecting a Cutoff Point There is often an overlap in test results for diseased and non-diseased population Sensitivity and specificity are influenced by the chosen cutoff point used to determine positive results Example: Immunofluorescence test for HIV based on optical density ratio (next slide)

28 Low Cutoff High sensitivity and low specificity

29 High Cutoff Low sensitivity and high specificity

30 Intermediate Cutoff moderate sensitivity & moderate specificity

31 Again,Snout and Spin Best strategy is to start with a very sensitive screening test. A negative test on a sensitive test rules out the disease You then proceed to rule in or confirm the disease by doing a test with high specificity. A positive test on a specific test rules in or confirms the diagnosis.